BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28873944)

  • 1. Protective efficacy by various doses of a new brucellosis vaccine candidate based on Salmonella strains expressing Brucella abortus BSCP31, Omp3b and superoxide dismutase against brucellosis in murine model.
    Kim WK; Moon JY; Cho JS; Hur J
    Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28873944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BCSP31, Omp3b and SOD proteins in Beagles.
    Kim WK; Moon JY; Cho JS; Park BY; Hur J
    J Vet Med Sci; 2018 Sep; 80(9):1373-1379. PubMed ID: 30068897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model.
    Kim WK; Moon JY; Kim S; Hur J
    Front Microbiol; 2016; 7():550. PubMed ID: 27148232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a
    Kim WK; Moon JY; Cho JS; Hur J
    Can J Vet Res; 2019 Oct; 83(4):261-266. PubMed ID: 31571725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models.
    Kwon AJ; Moon JY; Kim WK; Kim S; Hur J
    J Vet Med Sci; 2016 Nov; 78(10):1541-1548. PubMed ID: 27349900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of goats with a combination
    Leya M; Kim WK; Cho JS; Yu EC; Kim YJ; Yeo Y; Lyoo KS; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
    J Vet Sci; 2018 Sep; 19(5):643-652. PubMed ID: 29929362
    [No Abstract]   [Full Text] [Related]  

  • 8. Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge.
    Lalsiamthara J; Lee JH
    Vet Microbiol; 2017 Jun; 205():84-91. PubMed ID: 28622869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantial Protective Immunity Conferred by a Combination of
    Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
    J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.
    He Y; Vemulapalli R; Schurig GG
    Infect Immun; 2002 May; 70(5):2535-43. PubMed ID: 11953393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunization routes and protective efficacy of
    Lalsiamthara J; Won G; Lee JH
    J Vet Sci; 2018 May; 19(3):416-425. PubMed ID: 29366302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of immune responses in Balb/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine.
    Tabatabai LB; Pugh GW
    Vaccine; 1994 Aug; 12(10):919-24. PubMed ID: 7526568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.
    Yu DH; Hu XD; Cai H
    DNA Cell Biol; 2007 Jun; 26(6):435-43. PubMed ID: 17570767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunization efficacy and safety of
    Wei C; Yang WH; Hou XX; Yang HY; Sun LN; Zhou DS; Li ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1103-1109. PubMed ID: 32741179
    [No Abstract]   [Full Text] [Related]  

  • 20. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
    Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.